Recent Post
NSANZ secures charity status and appoints new President
VIVA! Communications is delighted to be teaming with the Neuromodulation Society of Australia and New Zealand (NSANZ) today (Tuesday, July 30, 2019) to announce their approved charity status, and appointment of their new President. The peak professional body for the practice of neuromodulation has been recognised for its invaluable role in striving to uphold the…
Read MoreNew blood cancer therapy granted TGA approval
There was some promising news for the Australian multiple myeloma community this month with the Therapeutic Goods Administration (TGA) approval of a new triplet therapy. Myeloma is a life-threatening blood cancer, not to be confused with the skin cancer, melanoma. It develops from plasma cells typically found in the bone marrow and can affect multiple…
Read MoreVIVA! Communications is celebrating 17 successful years
VIVA! is celebrating 17 years in business today, reinforcing our commitment to excellence and innovation in the healthcare arena. The birthday celebrations follow VIVA!s recent office expansion of our existing headquarters in Mosman, Sydney, following an influx of new healthcare clientele. Established in 2002 by Principal, Fellow of the Public Relations Institute of Australia (PRIA)…
Read MoreA pharmacist’s perspective on pneumococcal pneumonia
Pneumococcal pneumonia results in more than 77,000 hospitalisations and 4,000 deaths8 in Australia each year. Many of us carry pneumonia-causing bacteria in the back of our throats, which can take hold when the immune system becomes compromised or due to a viral infection such as the flu. Australians aged over 65 years are at significantly…
Read MoreDermatologists issuing urgent community plea to safeguard young Aussie lives
Given melanoma is our nation’s leading cancer affecting women (aged 20-to-24) and men (aged 35-to-50),1 the Australasian College of Dermatologists is today calling for early detection of skin cancer to save young Australian lives. The College’s plea is coinciding with an article just published in MJA Insight, in which the two co-authors, leading Queensland-based skin…
Read More